NCBiotech News

RTP's AgBiome has submitted its new biological fungicide, Theia, for EPA review -- the company's second such fungicide in three years

A study by Duke scientists shows that children growing up in impoverished surroundings develop genetic changes in adulthood that are typically associated with exposure to tobacco smoke and other pollutants.

RedHill Biopharma, with U.S. headquarters in Raleigh, is reporting positive early results from opaganib, one of its potential treatments for COVID-19.

Jude Samulski, a UNC gene therapy pioneer, has been awarded an international patent application by the World Intellectual Property Organization for his regulated gene-editing system.

Grant funding from NCBiotech is helping NC State researchers take an early but important step in moving DNA storage from exciting idea to functional reality. 

A Durham startup, BIOMILQ, has a mission to replicate the nutritional profile of breastmilk with mammary cells outside the body.

Azzur Labs, an analytical laboratory serving the biopharmaceutical and medical device industries, has named Marie France Quillen as senior director of the expanding Raleigh operation.

Armed with federal grants and contracts totaling nearly $600 million, Duke has leased 273,000 square feet that will be retrofitted in the Parmer RTP research and development campus for vaccine development.

UK-based MedPharm Ltd., which completed a $4 million expansion in Research Triangle Park just six months ago, is at it again, this time in Durham.

Santo Costa, an attorney and long-time pharmaceutical executive, has been elected chairman of the North Carolina Biotechnology Center’s Board of Directors.

Durham's Bio Products Laboratory USA has launched two new plasma therapies covering six serious medical conditions, as it also works on developing a COVID-19 treatment.

Durham-based FoodLogiQ, is collaborating with three other food industry technology leaders to keep the food supply safer by identifying and tracking products, so food companies can respond faster, with better results, when safety issues arise.

Durham's Path BioAnalytics is teaming up with impact investors and a digital health company to find a cure for pancreatitis.

Advanced Animal Diagnostics is using a $50,000 grant from NCBiotech, through a program established by the Wells Fargo Foundation, to “repurpose” its blood test platform designed to detect disease in cattle, to add a screen for COVID-19 in humans.

“The future of biopharma is in females,” said Mycovia CEO Patrick Jordan earlier this week during a panel discussion at the BIO Digital life sciences conference.